{
  "retracted": false,
  "timestamp": 1407369600000,
  "updates": [
    {
      "timestamp": 1495998327590,
      "identifier": {
        "doi": "10.1007/s40620-014-0128-2"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40620-014-0122-8"
  },
  "journal": "Journal of Nephrology",
  "publisher": "Springer Nature",
  "title": "Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study"
}
